Sichuan Huiyu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is CARFILZOMIB, with a corresponding US DMF Number 40758.
Remarkably, this DMF maintains an Active status since its submission on November 25, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 26, 2024, and payment made on November 27, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II